Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

35.57

-0.25 (-0.70%)

At close: Mar 20, 2026, 4:00 PM EDT

36.00

+0.43 (1.21%)

After-hours: Mar 20, 2026, 6:49 PM EDT

Crinetics Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-465.32	-298.41	-214.53	-163.92	-107.64
Depreciation & Amortization	3.89	2.79	1.1	0.98	0.92
Stock-Based Compensation	91.02	69.39	40.94	28.27	17.35
Other Adjustments	-12.36	-11.37	-1.86	0.85	-0.32
Change in Receivables	-0.59	-	-	-	-
Changes in Inventories	-2.02	-	-	-	-
Changes in Accounts Payable	28.98	13.32	12.36	10.99	6.29
Changes in Unearned Revenue	-1.84	0.07	-1.54	8.34	-
Changes in Other Operating Activities	-19.69	-5.98	-5.07	-0.72	-5.2
Operating Cash Flow	-377.92	-230.19	-168.6	-115.21	-88.59
Capital Expenditures	-5.76	-3.84	-4.69	-1.66	-0.44
Purchases of Investments	-1,004	-1,147	-532.86	-329.82	-125.4
Proceeds from Sale of Investments	1,184	575.8	337.13	157.49	69.36
Investing Cash Flow	173.91	-574.82	-200.41	-173.98	-56.48
Issuance of Common Stock	40.61	1,030	391.78	121.96	252.68
Net Common Stock Issued (Repurchased)	40.61	1,030	391.78	121.96	252.68
Other Financing Activities	-	-14.98	-0.54	-	-
Financing Cash Flow	40.61	1,015	391.24	121.96	252.68
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.11	-	-	-	-
Net Cash Flow	-163.4	209.65	22.22	-167.22	107.61
Free Cash Flow	-383.68	-234.04	-173.29	-116.86	-89.02
FCF Margin	-4985.50%	-22525.31%	-4318.12%	-2466.98%	-8258.26%
Free Cash Flow Per Share	-4.08	-2.90	-2.98	-2.25	-2.32
Levered Free Cash Flow	-461.76	-292.06	-212.37	-145.98	-106.06
Unlevered Free Cash Flow	-513.41	-332.5	-220.45	-149.94	-106.12

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q